Events

You are invited to attend an informative seminar detailing regulatory considerations and updated guidelines regarding the development and commercialization of cell and gene therapies. This seminar will feature Dr. Nimi Chhina, executive director and head of Global R&D and Regulatory Policy at BioMarin Pharmaceutical, Inc. Dr. Chhina will focus on key details surrounding:

• Unique regulatory considerations for cell and gene therapy product development
• Developing and informing a regulatory strategy for your project

Attendees will have the opportunity to sign up for a 1:1 meeting to discuss their project directly with Dr. Chhina. You must register and complete the meeting request form HERE in advance. Meetings will take place directly after the program. You will receive an invitation with the suggested timeslot once Dr. Chhina has reviewed all submissions.

This event is hybrid and will take place at Weill Cornell Medicine BioVenture eLab (1157 York Ave) for in-person attendees. Register here.

Are you an entrepreneur ready to take your product idea to the next level? Rev: Ithaca Startup Works invites you to take a deep dive into prototyping this summer!

Over 10 weeks, Rev’s Prototyping Hardware Accelerator guides product teams to determine if their ideas are commercially desirable, technologically feasible, and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers, and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype. 

The program offers four unique tracks with tailored content and instruction which include: 

• MedTech Track: Offered in partnership with Cornell Biomedical Engineering and Weill Cornell, the new MedTech track gain access to specialized prototyping equipment, regulatory resources, and research and medical professionals in the field.  

Applications are now being accepted for all tracks of the Summer 2024 Prototyping Hardware Accelerator! The accelerator is held in person at Rev: Ithaca Startup Works in Ithaca, New York beginning in late May 2024. The program is free and open to the public.   

Early admission deadline February 16, 2024. Applications close March 25, 2024. Apply here. 

*Want to learn more? Register to attend an upcoming virtual information session: 

• Thursday, February 8, 4-5:00 p.m. ET 
• Wednesday, March 20, 4-5 p.m. ET  

Note: Digital platforms, applications, and other software programs are not eligible unless paired with a physical product that you intend to develop in our program.  

The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. 

Endeavor Awards are $3,000,000 disbursed over a 3-year term.

• The requested funding should be divided amongst team members in a manner proportional to the actual cost of the work carried out by each investigator for the project.
• The budget limit includes both direct and indirect costs, with indirect costs not to exceed 10% of the direct costs.
• The third year of funding will be contingent on sufficient scientific progress as presented at the 18-month project review.
• The letter of agreement will include IP terms with a revenue sharing component

Grants portal opens for submission of Letters of Intent (LOI) on 1/3/2024. LOI submission deadline is 3/12/2024. To learn more about the eligibility and LOI guidelines, please visit The Mark Foundation website here. 

Wondering how to secure non-dilutive funding to take your startup to the next level?

Join Cornell University's Center for Regional Economic Advancement and Kirk Macolini, President of InteliSpark, LLC, for this virtual workshop providing insights into the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process.

During the workshop, Macolini will share an overview of the SBIR/STTR programs, discuss eligibility requirements, and tell you how to use SBIR/STTR to enhance your company's value. He'll also answer questions regarding:

• Writing and submitting a successful SBIR/STTR proposal
• Locating additional non-dilutive funding sources

Questions? Contact sbirassistance@cornell.edu.

Join us as the finalist teams from our 2023 Accelerating BioVenture Innovation (ABI) course pitch their technologies to a panel of early-stage investors and their peers. The judges for this year include:

• James Bellush, PhD'19, RTW Investments
• Lazar Bojic, PhD, Curie.Bio
• Silvia Codony, MBA, NY Ventures, NYS-ESD
• Adam Cotton, PhD, MBA, Novartis Venture Fund
• Matias Porras Paniagua, PhD, Associate, Insight Partners

The pitch event will take place at Uris Auditorium, 1300 York Ave, New York, NY. Following the pitches there will be a networking reception at Griffis Faculty Lounge (same location) with investors, ecosystem partners and industry representatives who served as mentors and lecturers throughout our program. Come celebrate the winning teams and WCM innovation with hors d'oeuvres and cocktails!

Register here. 

Research tools, such as cell lines, rodents, and reagents, are an essential part of exploring our unanswered scientific questions. While often overlooked for commercialization, licensing of research tools has the potential to reduce MTA burden and generate sizable financial returns. But what distinguishes an academic project from a successful commercial product?

Featuring:

• Karen Wu, Ph.D., President and Co-Founder at Lucerna
• James Hoberg, Ph.D., Head of External Innovation & Licensing, Millipore Sigma
• Chuck Na, MSc, Innovation Manager, ATCC
• Peter Wells, MBA, Contracts & Licensing Manager, The Jackson Laboratory
• Iris Bica, Business Development and Licensing Associate, Weill Cornell Medicine (Moderator)

Join the Center for Technology Licensing at Weill Cornell as we convene a panel of industry experts to learn about the research tools industry and the valuable research tools that might be hiding in your freezer. Register here. 

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell and Gene Therapy, Cardiovascular, Immunology, Radiology and Digital Health! Do you have that breakthrough innovation in health care but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

Bayer’s mission is to boost innovation in EMEA and bring it to the patients who need it most. We are looking to enable and support standout innovation in health care by providing cost-free mentorship and knowledge exchange.

Join Bayer's Expert Mondays, dedicated to topics that can support you, your innovation and your startup in its growth! Benefit from Bayer's global expertise, network with fellow founders and the Bayer Pharma team, and ask your questions.
 
Please note: These sessions are not intended for service providers, consultants, IT providers, etc., but are limited to drug developers and researchers in health care who are seeking collaboration with big pharma and out-licensing opportunities later in their journey.

Please note that recordings will not be sent to those who did not attend live.

This workshop is part of a virtual series presented by the Center for Regional Economic Advancement, a division of the Office of the Vice President for Research and Innovation at Cornell University. Designed to explore the entrepreneurial journey from ideation to operation, the series is open to anyone with a vision for a startup, including researchers, faculty, doctoral students, graduate students and undergraduates across Cornell’s campuses.

Join us to learn what to consider when choosing an accelerator or incubator. Questions? Contact crea@cornell.edu.

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell and Gene Therapy, Cardiovascular, Immunology, Radiology and Digital Health! Do you have that breakthrough innovation in health care but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

Bayer’s mission is to boost innovation in EMEA and bring it to the patients who need it most. We are looking to enable and support standout innovation in health care by providing cost-free mentorship and knowledge exchange.

Join Bayer's Expert Mondays, dedicated to topics that can support you, your innovation and your startup in its growth! Benefit from Bayer's global expertise, network with fellow founders and the Bayer Pharma team, and ask your questions.
 
Please note: These sessions are not intended for service providers, consultants, IT providers, etc., but are limited to drug developers and researchers in health care who are seeking collaboration with big pharma and out-licensing opportunities later in their journey.

Please note that recordings will not be sent to those who did not attend live.

The Daedalus Fund for Innovation is a unique initiative designed to advance early-stage applied and translational research projects that have clear, relatively near-term commercial potential. The core objective is to create resources to bridge the funding gap and accelerate research projects to the point at which they would be considered "partnership ready" with a goal of building a robust data validation package and generating (or strengthening) solid intellectual property positions to attract investment and commercialization partners from industry and the venture community.

What You Need to Know:

• Two categories of funding: Level I – funding of up to $200k for 1 year and Level II – funding of up to $200k per year for a period of 2 years
• Use the funding to advance inventions toward licensing, startup creation, or industry partnerships
• Open to Weill Cornell Medicine researchers with disclosed, active inventions that have been disclosed to Center for Technology Licensing at Weill Cornell

Pre-proposals are currently being accepted until November 27, 2023. Please submit applications to DaedalusFund@med.cornell.edu.

Successful applicants will be informed by mid-December 2023 and invited to submit full proposals for review by the Daedalus Fund’s independent external Scientific Advisory Committee.